Skip to content

Clinical trials

Completed Lymphoma, T-Cell, Peripheral trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Peripheral Status: Completed Country / region: South Korea Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20091
20121
20131
20164
20181
20192
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Samsung Medical Center2
Solasia Pharma K.K.2
Affimed GmbH1
Associazione Angela Serra per la ricerca sul cancro1
AstraZeneca1
Boryung Pharmaceutical Co., Ltd1
Chonnam National University Hospital1
Dizal Pharmaceuticals1
HUYABIO International, LLC.1
Innate Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Peripheral15
Recurrence4
Lymphoma, Extranodal NK-T-Cell3
Enteropathy-Associated T-Cell Lymphoma1
Immunoblastic Lymphadenopathy1
Leukemia, Lymphocytic, Chronic, B-Cell1
Lymphoma1
Lymphoma, B-Cell1
Lymphoma, B-Cell, Marginal Zone1
Lymphoma, Follicular1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.